| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17a65bc83ed569f525294332fa4787fc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2015-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65d7743d6dfbf88d44ea0e18b982440a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cce707a80b5f8223bd0a13b9de9537dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b46c20481f5b5932f362c31dacf7da59 |
| publicationDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016008366-A1 |
| titleOfInvention |
Btk inhibitors for the treatment of cns malignancies |
| abstract |
Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of CNS malignancies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111133315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020530467-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4036583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019033041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3665482-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406643-B2 |
| priorityDate |
2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |